Simplify Asset Management »

Syndax Pharmaceuticals shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $255k 12k 21.61
2023-09-30 $184k 13k 14.52
2023-06-30 $268k 13k 20.93

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding Syndax Pharmaceuticals

Wellington Management Company
Kynam Capital Management
Vanguard Group
venBio Select Advisor
Avidity Partners Management
Point72 Asset Management
Marshall Wace
BVF
OrbiMed Advisors
Franklin Resources
Goldman Sachs Group
Cormorant Asset Management
Bank of America Corporation
Aisling Capital Management
Candriam Luxembourg S.C.A.

View all funds holding Syndax Pharmaceuticals